Home › Funds › GREAT POINT PARTNERS LLC › IRD
GREAT POINT PARTNERS LLC position in IRD
OPUS GENETICS INC · Health Care
GREAT POINT PARTNERS LLC reported holding 1,970,187 shares of IRD (OPUS GENETICS INC) in its Q2 2026 13F filing — a position valued at US$8.1M, representing 1.70% of its reported portfolio and ranking #21 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed IRD holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GREAT POINT PARTNERS LLC's IRD position evolved
GREAT POINT PARTNERS LLC first disclosed a stake in IRD in Q1 2026 at 324,340 shares (US$1.5M). The position peaked in Q2 2026 at 1,970,187 shares, worth US$8.1M. Across 2 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,970,187 shares valued at US$8.1M — an increase of 1,645,847 shares quarter over quarter.. Notable position changes include a 507% increase in Q2 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 324.34K | $1.48M | New |
| Q2 2026 | 1.97M | $8.10M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRD and 13F data
IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include Caligan Partners LP (US$25.0M), BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRD
- Caligan Partners LP 6.08M sh · $24.98M · Q2 2026
- BIOS Capital Management, LP 3.68M sh · $15.14M · Q2 2026
- Boxer Capital Management, LLC 2.81M sh · $11.57M · Q2 2026
- Trails Edge Capital Partners, LP 2.74M sh · $11.28M · Q2 2026
- Opaleye Management Inc. 1.12M sh · $4.62M · Q2 2026
- Bleichroeder LP 736.84K sh · $3.03M · Q2 2026
- Mink Brook Asset Management LLC 161.21K sh · $662.55K · Q2 2026
More on GREAT POINT PARTNERS LLC
FAQ
How long has GREAT POINT PARTNERS LLC held IRD?
GREAT POINT PARTNERS LLC has disclosed IRD holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is GREAT POINT PARTNERS LLC's current position in IRD?
As of Q2 2026, GREAT POINT PARTNERS LLC holds 1.97M shares of IRD (OPUS GENETICS INC), valued at $8.10M, representing 1.70% of its reported portfolio and ranking #21.
Has GREAT POINT PARTNERS LLC been buying or selling IRD?
In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC increased its position in IRD. The position peaked in Q2 2026 at 1.97M shares.
Which other funds hold IRD?
Other major institutional holders of IRD include Caligan Partners LP, BIOS Capital Management, LP, Boxer Capital Management, LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.